Xspray Pharma AB (6XP) Ratios
2 Followers
Xspray Pharma AB Ratios
DE:6XP's free cash flow for Q2 2026 was kr-47.25M. For the 2026 fiscal year, DE:6XP's free cash flow was decreased by kr-10.31M and operating cash flow was kr-36.95M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.44 | 1.61 | 5.46 | 4.58 | 9.41 |
| Quick Ratio | 7.41 | 1.47 | 4.36 | 4.29 | 9.21 |
| Cash Ratio | 7.10 | 1.42 | 4.17 | 4.17 | 9.07 |
| Solvency Ratio | -1.01 | -1.62 | -2.37 | -4.11 | -2.82 |
| Operating Cash Flow Ratio | -8.92 | -1.52 | -5.09 | -3.82 | -1.72 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -2.32 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | kr 18.20M | kr 61.82M | kr 145.97M | kr 102.82M | kr 250.91M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.22 | 0.16 | 0.05 | 0.00 | 0.01 |
| Debt-to-Equity Ratio | 0.28 | 0.21 | 0.05 | 0.00 | 0.01 |
| Debt-to-Capital Ratio | 0.22 | 0.17 | 0.05 | 0.00 | 0.01 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.27 | 1.28 | 1.10 | 1.05 | 1.05 |
| Debt Service Coverage Ratio | -9.27 | -2.83 | -251.55 | -10177.17 | -21957.00 |
| Interest Coverage Ratio | -9.60 | -146.83 | -269.24 | -11089.42 | -24488.25 |
| Debt to Market Cap | 0.12 | 0.07 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 4.86 | 3.93 | 1.41 | 0.10 | 0.17 |
| Net Debt to EBITDA | -0.10 | 0.29 | 0.76 | 0.97 | 3.06 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 99.94% | 99.95% | 99.99% | 98.93% | 100.00% |
| EBT Per EBIT | 105.99% | 100.86% | 98.87% | 98.95% | 98.72% |
| Return on Assets (ROA) | -22.28% | -35.85% | -23.48% | -22.25% | -15.52% |
| Return on Equity (ROE) | -28.35% | -45.82% | -25.91% | -23.43% | -16.34% |
| Return on Capital Employed (ROCE) | -21.65% | -43.56% | -25.05% | -23.91% | -16.52% |
| Return on Invested Capital (ROIC) | -21.48% | -37.68% | -24.89% | -23.84% | -16.46% |
| Return on Tangible Assets | -66.67% | -89.95% | -54.70% | -65.19% | -29.60% |
| Earnings Yield | -14.18% | -20.80% | -17.79% | -10.75% | -7.77% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 1.68 | 0.50 | 0.74 | 0.64 | 0.53 |
| Inventory Turnover | 0.25 | 0.42 | 0.21 | 1.11 | 1.43 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 1241.29 | 138.88 | 1242.96 | -238.71 | -438.91 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 1458.69 | 868.41 | 1738.10 | 327.47 | 255.09 |
| Days of Payables Outstanding | 217.40 | 729.53 | 495.14 | 566.19 | 693.99 |
| Operating Cycle | 1458.69 | 868.41 | 1738.10 | 327.47 | 255.09 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -5.02 | -6.71 | -7.65 | -5.18 | -2.66 |
| Free Cash Flow Per Share | -5.78 | -7.99 | -9.68 | -11.22 | -7.60 |
| Dividend Paid and CapEx Coverage Ratio | -6.62 | -5.28 | -3.76 | -0.86 | -0.54 |
| Capital Expenditure Coverage Ratio | -6.62 | -5.28 | -3.76 | -0.86 | -0.54 |
| Operating Cash Flow Coverage Ratio | -1.14 | -1.73 | -5.52 | -51.82 | -15.96 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -18.39% | -19.27% | -25.48% | -19.68% | -11.86% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.05 | -4.81 | -5.62 | -9.30 | -12.87 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | 2.00 | 2.20 | 1.46 | 2.18 | 2.10 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -5.44 | -5.19 | -3.92 | -5.08 | -8.43 |
| Price-to-Operating Cash Flow Ratio | -6.26 | -6.17 | -4.97 | -11.00 | -24.11 |
| Price-to-Earnings Growth (PEG) Ratio | 0.15 | -0.17 | -0.55 | -0.40 | -0.20 |
| Enterprise Value Multiple | -7.84 | -4.65 | -5.18 | -8.96 | -11.11 |
| Enterprise Value | 1.23B | 1.29B | 880.47M | 1.09B | 975.74M |
| EV to EBITDA | -7.84 | -4.65 | -5.18 | -8.96 | -11.11 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -5.51 | -4.89 | -3.42 | -4.59 | -6.61 |
| EV to Operating Cash Flow | -6.35 | -5.81 | -4.33 | -9.93 | -18.91 |
| Tangible Book Value Per Share | 2.40 | 4.35 | 9.66 | 8.02 | 15.22 |
| Shareholders’ Equity Per Share | 15.72 | 18.81 | 26.09 | 26.15 | 30.48 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -4.46 | -8.62 | -6.76 | -6.13 | -4.98 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 0.99 | 1.00 |
| Interest Burden | 1.06 | 1.01 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.13 | 0.77 | 1.13 | 0.83 | 0.53 |
Currency in SEK
